SKI Market

A+| A| A-|

Indian Indices

Sensex

77,328.19 -516.33
( -0.66%)

Global Indices

Nasdaq

49,619.91 1.93
(0.00%)

Dow Jones

7,417.79 59.68
(0.81%)

Hang Seng

62,681.30 -152.54
(-0.24%)

Nikkei 225

10,228.01 -48.94
(-0.48%)

Forex

USD-INR

94.38 -0.30
(-0.31%)

EUR-INR

110.93 -0.26
(-0.23%)

GBP-INR

128.32 -0.39
(-0.30%)

JPY-INR

0.60 0.00
(-0.28%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Strides Pharma Science Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532531

INE939A01011

344.5797109

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

STAR

58.08

10653.78

EPS(TTM)

Face Value()

Div & Yield %

19.9

0.35

Back

Prismx Global Ventures consolidated net profit rises 38.10% in the December 2025 quarter

Feb 11,2026

Net profit of Prismx Global Ventures rose 38.10% to Rs 1.45 crore in the quarter ended December 2025 as against Rs 1.05 crore during the previous quarter ended December 2024. Sales declined 25.00% to Rs 0.27 crore in the quarter ended December 2025 as against Rs 0.36 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	0.27	0.36	-25
OPM %	-211.11	13.89	-
PBDT	1.52	1.23	24
PBT	1.49	1.22	22
NP	1.45	1.05	38

77,328.19 -516.33 ( -0.66%)

49,619.91 1.93 (0.00%)

7,417.79 59.68 (0.81%)

62,681.30 -152.54 (-0.24%)

10,228.01 -48.94 (-0.48%)

94.38 -0.30 (-0.31%)

110.93 -0.26 (-0.23%)

128.32 -0.39 (-0.30%)

0.60 0.00 (-0.28%)